back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2015-11-09 Tx date 2014-12-01 |
$NTB
Neptune Technologies & Bioressources Inc. |
Waksal, Harlan
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-750,000
-250,000 vol $3.00 each |
270,000 | |
| Filed 2015-11-09 Tx date 2015-01-01 |
$NTB
Neptune Technologies & Bioressources Inc. |
Waksal, Harlan
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-750,000
-250,000 vol $3.00 each |
20,000 | |
| Filed 2015-11-04 Tx date 2015-10-15 |
$NTB
Neptune Technologies & Bioressources Inc. |
Waksal, Harlan
4 - Director of Issuer
Direct Ownership
|
Call-options
37 - Stock split or consolidation
|
-382,500 vol |
||
| Filed 2015-11-04 Tx date 2015-10-15 |
$NTB
Neptune Technologies & Bioressources Inc. |
Waksal, Harlan
4 - Director of Issuer
Direct Ownership
|
Call-options
37 - Stock split or consolidation
|
-382,500 vol |
||
| Filed 2015-11-03 Tx date 2015-02-16 |
$APO
Acasti Pharma Inc. |
Waksal, Harlan
4 - Director of Issuer
Direct Ownership
|
Warrants (Séries 7)
55 - Expiration of warrants
|
$-562,500
-375,000 vol $1.50 each |
0 | |
| Filed 2015-11-03 Tx date 2015-10-15 |
$NTB
Neptune Technologies & Bioressources Inc. |
Waksal, Harlan
4 - Director of Issuer
Direct Ownership
|
Call-options
37 - Stock split or consolidation
|
-382,500 vol |
42,500 | |
| Filed 2015-11-03 Tx date 2015-02-16 |
$APO
Acasti Pharma Inc. |
Waksal, Harlan
4 - Director of Issuer
Direct Ownership
|
Warrants (Séries 6)
55 - Expiration of warrants
|
$-562,500
-375,000 vol $1.50 each |
0 | |
| Filed 2015-11-03 Tx date 2015-10-15 |
$APO
Acasti Pharma Inc. |
Waksal, Harlan
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
-820,080 vol |
91,120 | |
| Filed 2015-11-03 Tx date 2015-10-15 |
$APO
Acasti Pharma Inc. |
Waksal, Harlan
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-450,000 vol |
50,000 | |
| Filed 2015-11-03 Tx date 2013-10-08 |
$APO
Acasti Pharma Inc. |
Waksal, Harlan
4 - Director of Issuer
Direct Ownership
|
Warrants (Séries 4)
55 - Expiration of warrants
|
$-82,500
-165,000 vol $0.50 each |
0 | |
| Filed 2015-08-20 Tx date 2015-08-19 |
$APO
Acasti Pharma Inc. |
Waksal, Harlan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$48,000
+100,000 vol $0.48 each |
500,000 | |
| Filed 2015-06-17 Tx date 2015-06-15 |
$APO
Acasti Pharma Inc. |
Waksal, Harlan
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
57 - Exercise of rights
|
$13,500
+37,500 vol $0.36 each |
911,200 | |
| Filed 2015-06-16 Tx date 2015-06-15 |
$APO
Acasti Pharma Inc. |
Waksal, Harlan
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-13,500
-37,500 vol $0.36 each |
0 |